A NEW MARKER OF METABOLIC DISORDERS IN MEN WITH TYPE 2 DIABETES
https://doi.org/10.21886/2219-8075-2016-1-84-86
Abstract
Purpose: to evaluate the effect of the degree of severity of obesity on metabolic profile, the LAP index, leptin levels and C-reactive protein (CRP) in men with type 2 diabetes c.
Materials and methods: 120 male patients aged 40-65 years with obesity and Type 2 diabetes (mean age 54.3 ± 5.3 years). To assess the influence of the degree of severity of obesity on metabolic parameters was undertaken a comparative analysis of the data, depending on the body mass index (BMI). The metabolic profile was evaluated in terms of lipid profile, fasting glucose, of HbA1c, insulin resistance index HOMA. The study of leptin and CRP concentrations produced using laboratory kits for ELISA eBioscience (Austria). We used a new indicator for the integrated assessment of metabolic and cardio-vascular risks — LAP index.
Results: analysis revealed no significant differences in fasting glucose, HbA1c and total cholesterol (TC) between the groups. In all groups, the study revealed an increase HOMA index from the first to the fourth group, which indicates an increase in the severity of insulin resistance.
Summary: the increase in body mass index is a factor that by enhancing insulin resistance and adipokines production, leading to aggravation of metabolic disorders and the rise of cardiovascular risk in men with obesity and type 2 diabetes. LAP index is a more accurate marker of metabolic disorders than conventional carbohydrate and lipid metabolism.
About the Authors
I. A. Khripun
Rostov State Medical University Department of Endocrinology with a course of pediatric endocrinology, Department of Urology and Reproductive Health with the course of pediatric urology and andrology,
29 Nakhichevansky st., Rostov-on-Don, Russia, 344022
Russian Federation
Russian Federation
S. V. Vorobyev
Rostov State Medical University Department of Endocrinology with a course of pediatric endocrinology, Department of Urology and Reproductive Health with the course of pediatric urology and andrology,
29 Nakhichevansky st., Rostov-on-Don, Russia, 344022
Russian Federation
Russian Federation
M. I. Kogan
Rostov State Medical University Department of Endocrinology with a course of pediatric endocrinology, Department of Urology and Reproductive Health with the course of pediatric urology and andrology,
29 Nakhichevansky st., Rostov-on-Don, Russia, 344022
Russian Federation
Russian Federation
References
1. Аметов А.С. Избранные лекции по эндокринологии / Москва: МИА. 2012. 543с.
2. Canoy D. Distribution of body fat and risk of coronary heart disease in men and women // Curr. Opin. Cardiol. 2008. Vol. 23, N 6. P.591-598.
3. Аметов А.С., Камынина Л.Л. Проблема висцерального ожирения в диабетологии (патогенетические, клинические и эпидемиологические аспекты) // Эндокринология. 2012. № 1. С. 1-8.
4. Дедов И.И., Балаболкин М.И., Мамаева Г.Г., Клебанова Е.М., Креминская В.М. Инсулиновая резистентность и роль гормонов жировой ткани в развитии сахарного диабета: пособие для врачей / Эндокринологический научный центр РАМН и кафедра эндокринологии ММА им И.М. Сеченова. Москва, 2005. 88 с.
5. Hoube A.J., Eringa E.C., Jonk A.M. et al. Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease // Curr. Cardiovasc. Risk Rep. 2012. Vol. 6, N 1. P. 80-90.
6. Reaven G.M. Insulin resistance: the link between obesity and cardiovascular disease // Med. Clin. North Am. 2011. Vol. 95, N 5. P. 875-892.
7. Mirmiran P., Bahadoran Z., Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients // Endocrinol Metab (Seoul). 2014. Vol. 29, № 4. Р. 443-449.
Review
For citations:
Khripun I.A., Vorobyev S.V., Kogan M.I. A NEW MARKER OF METABOLIC DISORDERS IN MEN WITH TYPE 2 DIABETES. Medical Herald of the South of Russia. 2016;(1):84-86. (In Russ.) https://doi.org/10.21886/2219-8075-2016-1-84-86
Views:
576
Email this article 